The trustee filed a motion in the US Bankruptcy Court for the sale of certain assets of Generex Biotechnology Corporation on December 1, 2023. The trustee seeks the Court?s approval for the sale of its certain assets to Beijing Youfeng Biological Technology Co., Ltd., for a purchase price of $0.01 million in cash, waive or withdraw the proof of claim in the amount of $55.1 million, and assign to Debtor all claims it has against Mazars, with good-faith deposit in the amount of $0.01 million. The debtor?s assets include equity of various subsidiaries and any remaining intellectual property owned by Generex Biotechnology Corp.